Zenas BioPharma, Inc. (ZBIO) stock
ZBIONasdaqPharmaceutical PreparationsFiscal year ends December 31
$27.75−0.18 (-0.64%)
Close on Nov 17, 2026Market cap $1.81BP/E –Yield –
Zenas BioPharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Zenas BioPharma's price to book ratio was 7.4× on Nov 11, 2026, against 8.3× a year earlier. Over the last 2 years it ranged from 0.9× to 8.3×, with a median of 3.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 7.4× | −0.4 |
| 2025 | Dec 31, 2025 | 7.8× | +6.9 |
| 2024 | Dec 31, 2024 | 1.0× | – |
See a number that looks wrong?